Ideaya Biosciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $8,857 | $6,560 | $10,876 | $207,834 |
Gross Profit | 8,857 | 5,417 | -75,723 | 124,841 |
EBITDA | -110,188 | -97,396 | -82,076 | 120,274 |
EBIT | -112,452 | -98,539 | -83,273 | 119,244 |
Net Income | -112,452 | -98,539 | -83,273 | 119,244 |
Net Change In Cash | 8,857 | 6,560 | 10,876 | 207,834 |
Free Cash Flow | -165,214 | -76,137 | -90,829 | 142,172 |
Cash | 272,589 | 157,522 | 112,825 | 298,927 |
Basic Shares | 92,061 | 88,699 | 88,582 | 89,690 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $218,710 | $7,000 | $23,385 | $50,931 |
Gross Profit | 214,117 | 3,166 | 19,377 | 50,931 |
EBITDA | -109,105 | -270,643 | -108,953 | -60,401 |
EBIT | -113,698 | -274,477 | -112,961 | -62,502 |
Net Income | -113,698 | -274,477 | -112,961 | -54,808 |
Net Change In Cash | 218,710 | 7,000 | 23,385 | 50,931 |
Cost of Revenue | -23,414 | |||
Free Cash Flow | -73,466 | -251,441 | -117,592 | -90,618 |
Cash | 112,825 | 84,378 | 157,018 | 68,632 |
Basic Shares | 88,485 | 81,678 | 57,519 | 41,444 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.22 |
2026-03-31 | -$1.11 |
2025-12-31 | -$0.94 |
2025-09-30 | $1.33 |